Blood substitutes.
作者信息
Spahn D R
机构信息
Institut für Anästhesiologie, UniversitätsSpital, Zürich, Switzerland.
出版信息
Crit Care. 1999;3(5):R91-2. doi: 10.1186/cc363. Epub 1999 Sep 24.
Abstract
摘要
相似文献
1
Blood substitutes.
Crit Care. 1999;3(5):R91-2. doi: 10.1186/cc363. Epub 1999 Sep 24.
2
Artificial blood substitutes.
Transfus Sci. 1992 Jul;13(3):357-70. doi: 10.1016/0955-3886(92)90148-A.
3
Current perspectives on blood substitutes.
Curr Surg. 1987 Jul-Aug;44(4):279-81.
4
Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice?
Acta Anaesthesiol Belg. 2003;54(4):299-300.
5
Blood substitutes in surgery.
Surgery. 2000 Jun;127(6):599-602. doi: 10.1067/msy.2000.106462.
6
[Natural blood and artificial blood in rapid vascular filling].
Cah Anesthesiol. 1986 May;34(3):205-7.
7
[Research progress of blood substitutes for the treatment of hemorrhagic shock].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Apr;27(2):453-7.
8
Oxygen carriers ("blood substitutes").
Issues Emerg Health Technol. 2001 Jul(21):1-6.
9
Blood substitutes: where do we stand today?
J Intern Med. 2003 May;253(5):495-7. doi: 10.1046/j.1365-2796.2003.01147.x.
10
Blood substitutes: where do we stand with the fluorocarbon approach?
Curr Surg. 1988 Sep-Oct;45(5):365-70.
引用本文的文献
1
Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.
PLoS One. 2017 Sep 5;12(9):e0184250. doi: 10.1371/journal.pone.0184250. eCollection 2017.
2
The Emulsified PFC Oxycyte Improved Oxygen Content and Lung Injury Score in a Swine Model of Oleic Acid Lung Injury (OALI).
Lung. 2016 Dec;194(6):945-957. doi: 10.1007/s00408-016-9941-9. Epub 2016 Oct 4.
3
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.
Crit Care. 2011;15(2):R83. doi: 10.1186/cc10078. Epub 2011 Mar 4.
本文引用的文献
1
Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.
Anesthesiology. 1999 Nov;91(5):1195-208. doi: 10.1097/00000542-199911000-00009.
2
Transfusion medicine. Second of two parts--blood conservation.
N Engl J Med. 1999 Feb 18;340(7):525-33. doi: 10.1056/NEJM199902183400706.
3
Transfusion medicine. First of two parts--blood transfusion.
N Engl J Med. 1999 Feb 11;340(6):438-47. doi: 10.1056/NEJM199902113400606.
4
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
N Engl J Med. 1999 Feb 11;340(6):409-17. doi: 10.1056/NEJM199902113400601.
5
Artificial cells with emphasis on cell encapsulation of genetically engineered cells.
Artif Organs. 1998 Nov;22(11):958-65. doi: 10.1046/j.1525-1594.1998.06243.x.
6
Artificial oxygen carriers.
Eur J Anaesthesiol. 1998 Sep;15(5):571-84. doi: 10.1046/j.1365-2346.1998.00356.x.
7
Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
Vox Sang. 1998;74 Suppl 2:233-41. doi: 10.1111/j.1423-0410.1998.tb05425.x.
8
Clinical development of human polymerized hemoglobin as a blood substitute.
World J Surg. 1996 Nov-Dec;20(9):1200-7. doi: 10.1007/s002689900183.
9
Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
Anesthesiology. 1996 Mar;84(3):732-47.
10
Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions.
Anesth Analg. 1994 May;78(5):1000-21. doi: 10.1213/00000539-199405000-00029.
Zotero 插件